I see, so would also agree that aduhelm and lemquebi did not just scrape by since they were in fact approved despite their limited efficacy and less than optimal safety record?
Aside from that then, I hope you will agree I posted only fact?
My use of scrape by is another version of saying "Proof of Concept" trial, which I guess sounds better as an Anavex approved term.
Too much emotion and too little experienced cool calm review of fact is not a good strategy in biotech investing.
When people study for their law licence or any other exam a pass is a pass is a pass even if they just scrape by so ya these brain afflictions are extremely difficult to treat ( almost impossible) so just yanking this treatment barely across the finish line would suit me just extraordinarily beautifully fine ,,, so steady don’t get all twisted up in knots over a descriptor that denotes a PASS